Document is current
Any future updates will be listed below
-
Authors
Gong, Yin
Li, Xiangcheng
Wang, Mingming
-
Funding
Funding for this research was provided by:
study on the role and mechanism of ASPM alternative splicing mediated by the RBM10 C761Y mutation in hilar cholangiocarcinoma ((No. 82273066))
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 7 August 2025
First Online: 26 September 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committees of The First Affiliated Hospital of Nanjing Medical University and The Affiliated Jiangning Hospital of Nanjing Medical University having ethical approval number (2023YJK87ZH). Written informed consent was obtained from all participants prior to sample collection.
: Not applicable.
: The authors declare no competing interests.
